Bart Molemans

EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

Kausik K. Ray, Bart Molemans, W. Marieke Schoonen et al. · European Journal of Preventive Cardiology · 2020 · 699 citations · Full text

The OPTIMA Study

Piergiorgio Messa, Fernando MacaCombining Acute Accentrio, Magdi Yaqoob et al. · Clinical Journal of the American Society of Nephrology · 2008 · 220 citations · Full text

Hemoglobin Variability Does Not Predict Mortality in European Hemodialysis Patients

Kai‐Uwe Eckardt, Joseph Kim, Florian Kronenberg et al. · Journal of the American Society of Nephrology · 2010 · 65 citations · Full text

Hemodialysis, Hypertension, Renal Function +14

An Epidemiological Study of Hemodialysis Patients Based on the European Fresenius Medical Care Hemodialysis Network: Results of the ARO Study

Ángel L.M. de Francisco, Joseph Kim, Stefan D. Anker et al. · Nephron Clinical Practice · 2010 · 25 citations · Full text

A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis

Xavier Bonafont, A. Böck, D. Carter et al. · Clinical Kidney Journal · 2009 · 21 citations · Full text

Dialysis, Dialysis Therapy, Pharmacotherapy +18